Aspira Women's Health Inc.
AWHL· OTC
AWHLAspira Women's Health Inc.
Released Nov 13, 2023, after the close
10-Q filed Nov 13, 2023, 44 days after period end · 0000926617-23-000095
| Metric | Q3 2023 | Q3 2022 | Q3 2021 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $2.22M | $2.07M | $1.67M | $1.24M |
| Net Income | -$4.71M | -$7.78M | -$9.71M | -$4.29M |
| EPS Diluted |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$0.48 |
| -$1.00 |
| -$0.09 |
| -$0.04 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
